How to Determine Your Company's Valuation
Business valuation methods range from EBITDA multiples to discounted cash flow. Which one applies depends on your industry, size, and buyer type.
Business valuation methods generally fall into three categories: EBITDA multiple analysis, discounted cash flow, and asset-based valuation, and which one a buyer actually uses depends heavily on your industry, size, and the type of buyer at the table. For most privately held, founder-led businesses in the $2 million to $50 million revenue range, an EBITDA multiple is the method that ends up driving the real conversation, even when other methods appear in a formal valuation report.
Understanding how these methods work, and which one applies to your situation, helps you see your business the way a buyer will, instead of anchoring on a number that has little to do with how the deal will actually get priced.
Part of our Exit Planning series. Start with Business Exit Planning: A Founder's Roadmap for the complete framework.
The three primary valuation methods, compared
EBITDA multiple. The business's earnings before interest, taxes, depreciation, and amortization are multiplied by a factor drawn from comparable transactions in your industry. A landscaping platform might trade at 4 to 6 times EBITDA, while a specialty healthcare practice with strong provider economics might command a materially higher multiple. This method dominates middle-market M&A because it is straightforward to benchmark against real deal data.
Discounted cash flow (DCF). Projects future cash flows and discounts them back to present value using a rate that reflects risk. DCF is theoretically rigorous but highly sensitive to the growth and discount rate assumptions, which makes it easier to manipulate and harder to defend in a negotiation than a multiple grounded in comparable deals.
Asset-based valuation. Values the business based on the fair market value of its assets minus liabilities. This method matters most for asset-heavy businesses or distressed situations, and rarely drives price in a healthy, growing, founder-led business.
In practice, sophisticated buyers triangulate across methods but anchor primarily on EBITDA multiple for operating businesses, then adjust for quality of earnings, customer concentration, and owner dependence.
Why the same business can get two very different offers
It is common for a founder to receive wildly different informal valuations from different sources: a rule-of-thumb multiple from an industry peer, a higher number from a business broker eager to win the listing, and a lower number from a strategic buyer's initial indication of interest. These differences usually come down to what each party is actually applying the multiple to, and how much adjustment they are making for risk factors specific to your business.
A broker's early estimate is often based on top-line revenue multiples or optimistic EBITDA add-backs that have not yet been tested. A strategic buyer's diligence team will normalize EBITDA far more conservatively, removing one-time gains, adjusting owner compensation to market rate, and discounting for customer concentration or unclear financials. The gap between those two numbers is not dishonesty on either side. It reflects how much uncertainty exists in the underlying earnings before real diligence happens.
The practical takeaway is that any valuation estimate is only as strong as the earnings quality behind it. A founder who wants a credible number should assume a buyer's more conservative normalization will apply, and build the financial cleanliness that supports that number before ever starting a sale conversation.
Common mistakes founders make when estimating their own valuation
The most frequent mistake is anchoring on revenue rather than EBITDA. Two businesses with identical revenue can have wildly different valuations if one runs a 25 percent EBITDA margin and the other runs 8 percent. The second most frequent mistake is comparing your business to a broad industry multiple without adjusting for your specific risk profile: customer concentration, owner dependence, and growth trajectory all move the applicable multiple up or down from any generic benchmark.
A third common mistake is failing to normalize EBITDA for owner-specific add-backs correctly. Some add-backs are legitimate, a one-time legal expense, for example. Others, like understating owner compensation to inflate reported profit, tend to get challenged and reversed during real diligence, which means they should not be counted on when estimating value informally either.
Two questions about the numbers themselves
Should I get a formal valuation before talking to any potential buyer? A formal valuation is useful for internal planning, estate purposes, or partner buyouts, but real buyers will run their own valuation regardless. The more valuable exercise is often ensuring your EBITDA and its supporting documentation would survive a buyer's own analysis.
How often should a founder update their valuation estimate? Annually is reasonable for a business not actively planning a near-term sale, since market multiples and business performance both shift over a year.
What most affects your applicable multiple
- Consistency and verifiability of reported EBITDA
- Customer or payer concentration
- Owner dependence across leadership and client relationships
- Revenue growth trajectory and its sustainability
- Industry-specific benchmark multiples for comparable transactions
- Quality and completeness of financial documentation
Getting a credible read on your own number
A useful first step before any formal valuation exercise is an assessment of the specific factors that move your multiple up or down: earnings quality, customer concentration, owner dependence, and growth trajectory. Understanding where your business currently sits on each of these dimensions gives you a far more actionable picture than a single multiple applied to your EBITDA in isolation.
A scenario showing how normalization changes the number
A founder estimates his $7 million revenue business at a $4.5 million valuation based on a 5x multiple applied to reported EBITDA of $900,000. A buyer's diligence team normalizes that EBITDA down to $650,000 after adjusting owner compensation to market rate, removing a one-time insurance settlement, and reducing add-backs for personal expenses run through the business. The same 5x multiple applied to the normalized number produces a valuation closer to $3.25 million, over a million dollars lower than the founder's initial estimate.
Neither number is wrong exactly. They reflect different levels of scrutiny applied to the same underlying business. The gap is the reason financial cleanliness, ensuring reported EBITDA is defensible before a buyer ever gets involved, matters as much as the multiple itself.
The multiple itself is only half the equation. The EBITDA number it gets applied to has to survive scrutiny, which is where financial cleanliness and metrics becomes directly relevant: buyers discount or walk away from earnings they cannot verify.
Business Exit Planning: A Founder's Roadmap covers the broader timeline this valuation work fits into. the Keystone Enterprise Value Index scores your specific enterprise value drivers today.
